Chemical Structure (Oxcarbazepine 01)
Oxcarbazepine Suspension
Product Images NDC 51672-1393
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 51672-1393). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Oxcarbazepine 02)
This text contains information related to a log-rank test with a p-value of 0.0001. It also includes a table with data related to a Time on trial from Day 2 and mentions a Treatment Group using Oxcarbazepine.*
Figure 2 (Oxcarbazepine 03)
This text provides information on the seizure rate in a treatment group with oxcarbazepine and a placebo. The data includes the days from the first dose to the first seizure for both treatment options.*
Figure 3 (Oxcarbazepine 04)
This text provides information on the exit rate in a study, specifically mentioning a Tog-rank test with a p-value of 0.0001. It also lists time points (10 to 130 days) and indicates two treatment groups, one labeled as HIGH and the other as LOW. This data seems to refer to an analysis related to the time to exit for different treatment groups.*
Figure 4 (Oxcarbazepine 05)
This is a description of an analysis of exit rate using the log-rank test with a p-value of 0.0001. The data includes time to exit in days for two treatment groups: a high group with values of 60, 70, 80, 90, 100, 110, 120, and 130, and a low group with values of 30, 40, and 50.*
Principal Display Panel (250 mL Bottle Carton)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
